l-mind trial in relapsed/refractory dlbcl
Published 4 years ago • 1K plays • Length 6:37Download video MP4
Download video MP3
Similar videos
-
1:32
dr. kahl on findings from the l-mind study with tafasitamab in dlbcl
-
1:22
dr. burke on the ongoing first-mind trial with tafasitamab in dlbcl
-
2:24
results of the l-mind trial in r/r dlbcl
-
3:05
emerging treatments for relapsed/refractory dlbcl
-
7:46
relapsed/refractory dlbcl
-
1:16
dr. flinn on the utility of tafasitamab in relapsed/refractory dlbcl
-
5:32
relapsed/refractory dlbcl: unmet needs
-
6:05
l-mind study: r/r dlbcl
-
4:32
how is relapsed/refractory dlbcl treated?
-
1:33
dr. kahl on the utility of tafasitamab/lenalidomide in dlbcl
-
2:50
tafasitamab-lenalidomide in r/r dlbcl: clinical trial results and real-world data
-
1:35
long-term follow-up of tafasitamab and lenalidomide in r/r dlbcl
-
3:16
cd19-targeted mabs in relapsed/refractory dlbcl
-
1:01
dr. ritchie on the rationale of the aim trial in relapsed/refractory mantle cell lymphoma
-
4:39
treatment alternatives to chemotherapy in r/r dlbcl
-
1:31
long-term outcomes with tafasitamab plus lenalidomide for r/r dlbcl
-
1:36
the use of tafasitamab and lenalidomide in r/r dlbcl
-
5:51
re-mind versus l-mind regimen
-
21:56
what's new in the approach to dlbcl upfront and in the relapsed setting beyond car t